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LETTERS
Novel Bunyavirus  
in Domestic and 
Captive Farmed 
Animals,  
Minnesota, USA
To the Editor: Xing et al. (1) 
conclude that evidence of infection 
with a severe fever with thrombocy-
topenia syndrome (SFTS)–like virus 
or Heartland-like virus (HRTV) was 
found in many captive large mammals 
from much of Minnesota, raising the 
specter of widespread distribution of a 
novel pathogen. Although it is likely 
that HRTV can be found beyond the 
areas in northwestern Missouri, where 
it was discovered (2), we contend that 
this conclusion is not substantiated 
by the data presented by Xing et al., 
which were generated by an assay that 
was developed to diagnose SFTS virus 
infections in China (1,3). The study 
used an ELISA developed for an SFTS 
virus recombinant nucleocapsid pro-
tein that detects SFTS-reactive anti-
bodies (3). The conclusions reached 
by Xing et al. are based on the as-
sumption that the SFTS assay devel-
oped in China will cross-react with 
HRTV antibodies (1). This assump-
tion remains unsupported because the 
SFTS assay has not been evaluated 
for cross-reaction with antibodies to 
other non-SFTS members of the ge-
nus Phlebovirus (1,3). In addition, it 
is well recognized that serologic tests, 
like the ELISA, are often group reac-
tive (4), requiring neutralization tests 
to confirm antibody presence and pro-
vide specificity. Alternative explana-
tions include the possibility that posi-
tive results from testing by Xing et al. 
may have been caused by cross-reac-
tion with antibodies directed against 
other known tick-associated phlebo-
viruses endemic to North America, 
such as Lone Star virus (5), which is 
not known to be pathogenic. In the ab-
sence of confirmatory data generated 
by an independent method, the report 
by Xing et al. (1) should be considered 
speculative. Reports suggesting sub-
stantial expansion in the geographic 
range of a pathogenic organism should 
be based on rigorously validated labo-
ratory methods.
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In Response: We welcome the 
critiques of Nasci et al. (1), who may 
have misinterpreted the point of our 
Dispatch. Regarding identification of 
Heartland virus (HLV) in farm ani-
mals, in our article (2), we stated that 
“the viruses detected in this region 
are most likely HLV or close rela-
tives of HLV,” which indicates that 
the exact identification of the viruses 
in the animals in Minnesota will not 
be confirmed until the viruses are iso-
lated and/or the genomic sequence 
data are available. 
The underlying data were ob-
tained with an ELISA specific to se-
vere fever with thrombocytopenia 
syndrome virus (SFTSV). The conclu-
sion was based on our knowledge, at 
the time our manuscript was submit-
ted, that in North America no other 
known phleboviruses of this expanded 
Uukuniemi group that contains SFTSV 
and HLV were reported to be cross-re-
active with SFTSV. When tested by us-
ing our reagent, SFTSV was not cross-
reactive with Rift Valley fever virus. 
Related phleboviruses of this group 
(e.g., Bhanja, Palma, Forecariah, and 
Kismayo viruses) have not been report-
ed in North America (3). Phleboviruses 
of this group, such as Murre virus and 
RML-105355 virus, and Sunday Can-
yon virus, were isolated in Alaska and 
Texas, respectively, but are not cross-
reactive with SFTSV (4). 
Other bunyaviruses in North 
America (e.g., Cache Valley virus and 
California serogroup viruses) are dis-
tantly related and have ≈11% amino 
acid sequence homology to SFTSV. 
The recently characterized Lone Star 
virus appears to be the closest relative 
to SFTSV and HLV and may cross-re-
act with SFTSV and HLV, as also sug-
gested by Nasci et al., but this virus is 
apparently known only from 1 isolate 
obtained in 1967 (5). These data sug-
gest that SFTSV is not serologically 
cross-reactive with the known Un-
kuniemi group viruses that are current-
ly being transmitted in North America. 
Our report shows that tickborne 
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phleboviruses, which are closely re-
lated to SFTSV and HLV, may be 
more generally distributed in the 
midwestern United States and em-
phasizes the need to substantiate our 
serologic evidence with virus isolation 
and genomic characterization, which 
are underway.
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Infectious  
Schmallenberg  
Virus from Bovine 
Semen, Germany
To the Editor: The teratogenic 
Schmallenberg virus (SBV) (genus 
Orthobunyavirus) was detected in 
bovine semen in a recent German 
field study (1). Vector-borne trans-
mission by Culicoides spp. biting 
midges is most common (2), but ve-
nereal transmission of SBV might 
contribute to the spread of this virus 
to previously unaffected regions. We 
investigated the infectivity of SBV 
RNA–positive semen by experimen-
tal subcutaneous injection of cattle 
and interferon α/β receptor–deficient 
(IFNAR-/-) mice (3).
Commercially produced semen 
straws with egg yolk–based diluent 
were used for the injection of 6- to 
9-month-old heifers. The straws origi-
nated from 6 semen batches (quanti-
fication cycle [C
q
] values 26.4–36.4) 
collected from 6 bulls (designated 
A–C and E–G) during August and 
September 2012 (1). To increase the 
probability of SBV infection of inject-
ed cattle, 5 straws of semen (≈220 µL 
each) from 1 batch from an individual 
bull were pooled and diluted in mini-
mal essential medium with antibiotics 
to 4 mL. Six cattle (C1–6) were subcu-
taneously inoculated, each with a pool 
from 1 of the 6 bulls. To investigate 
the infectivity of a single insemination 
dose (1 straw), 5 cattle (C7–C11) were 
subcutaneously injected with single 
straws from bull F that had been con-
firmed to contain infectious SBV. Se-
rum samples were obtained on several 
days (Figure), and clinical signs and 
rectal body temperatures for the in-
jected cattle were monitored daily.
In addition, 20 SBV RNA–posi-
tive semen batches (C
q
 25.9 to 36.5) 
collected from 11 bulls (A–K) during 
August–November 2012 (1) were sub-
cutaneously injected into 40 IFNAR-/- 
mice (4–6 weeks old). For each batch, 
2 mice were each injected with half 
of a semen straw (80–120 µL). All 
mice were monitored clinically and 
weighed daily. Samples of serum, 
liver, and spleen were harvested im-
mediately after euthanasia at 22 days 
postinjection (dpi).
All serum samples and organ 
homogenates were tested for SBV 
RNA by using small segment–specific 
quantitative reverse transcription PCR 
(4). Serum samples were tested for 
SBV-specific antibodies by using the 
ID Screen Schmallenberg Virus Com-
petition ELISA (IDvet, Montpellier, 
France), according to the manufactur-
er’s instructions; selected serum sam-
ples were also tested by neutralization 
test against an original SBV isolate 
from Germany, as described (5).
SBV infection was confirmed in 5 
of 11 injected cattle: C3, C5, and C9–
C11. SBV RNA (C
q
 25.0–29.3) was 
first detected in serum at 3 to 6 dpi and 
persisted for 2–4 days. Seroconversion 
occurred at 8–12 dpi (Figure). None 
of the SBV-infected animals showed 
obvious clinical signs or fever; this 
finding is in accordance with reports 
of subclinical SBV infection in adult 
cattle (5–7). Samples from the other 6 
cattle and all IFNAR-/- mice had nega-
tive results (data not shown).
The 2 infectious semen batches 
contained moderate (C
q
 26.4) or low 
(C
q
 34.2) viral loads of SBV RNA, 
indicating that a high sensitivity is 
required for reliable SBV RNA de-
tection in semen samples (1). The on-
set of SBV infection in the 3 animals 
injected with single semen straws 
ranged from 3 to 5 dpi, and not ev-
ery straw was infectious, although 
biologic and technical replicates of 
straws from 1 semen batch showed 
similar PCR results (data not shown) 
(1). Possible explanations for differ-
ences in the infectivity of individual 
straws are that the viral RNA load of 
an SBV-containing straw does not 
necessarily correlate with infectiv-
ity or that the infectivity of 1 straw 
is lower than the minimal cattle 
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